Literature DB >> 21911578

Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

Anastassia V Komarova1, Chantal Combredet, Laurène Meyniel-Schicklin, Manuel Chapelle, Grégory Caignard, Jean-Michel Camadro, Vincent Lotteau, Pierre-Olivier Vidalain, Frédéric Tangy.   

Abstract

RNA viruses exhibit small-sized genomes encoding few proteins, but still establish complex networks of interactions with host cell components to achieve replication and spreading. Ideally, these virus-host protein interactions should be mapped directly in infected cell culture, but such a high standard is often difficult to reach when using conventional approaches. We thus developed a new strategy based on recombinant viruses expressing tagged viral proteins to capture both direct and indirect physical binding partners during infection. As a proof of concept, we engineered a recombinant measles virus (MV) expressing one of its virulence factors, the MV-V protein, with a One-STrEP amino-terminal tag. This allowed virus-host protein complex analysis directly from infected cells by combining modified tandem affinity chromatography and mass spectrometry analysis. Using this approach, we established a prosperous list of 245 cellular proteins interacting either directly or indirectly with MV-V, and including four of the nine already known partners of this viral factor. These interactions were highly specific of MV-V because they were not recovered when the nucleoprotein MV-N, instead of MV-V, was tagged. Besides key components of the antiviral response, cellular proteins from mitochondria, ribosomes, endoplasmic reticulum, protein phosphatase 2A, and histone deacetylase complex were identified for the first time as prominent targets of MV-V and the critical role of the later protein family in MV replication was addressed. Most interestingly, MV-V showed some preferential attachment to essential proteins in the human interactome network, as assessed by centrality and interconnectivity measures. Furthermore, the list of MV-V interactors also showed a massive enrichment for well-known targets of other viruses. Altogether, this clearly supports our approach based on reverse genetics of viruses combined with high-throughput proteomics to probe the interaction network that viruses establish in infected cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911578      PMCID: PMC3237069          DOI: 10.1074/mcp.M110.007443

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  50 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.

Authors:  Hao-Ming Chang; Matthew Paulson; Michelle Holko; Charles M Rice; Bryan R G Williams; Isabelle Marié; David E Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 3.  Reverse genetics of mononegavirales.

Authors:  K K Conzelmann
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

Review 4.  Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA.

Authors:  G Neumann; Y Kawaoka
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

5.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

6.  A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice.

Authors:  Chantal Combredet; Valérie Labrousse; Lucile Mollet; Clarisse Lorin; Frédéric Delebecque; Bruno Hurtrel; Harold McClure; Mark B Feinberg; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Measles virus protein interactions in yeast: new findings and caveats.

Authors:  M Chen; J C Cortay; D Gerlier
Journal:  Virus Res       Date:  2003-12       Impact factor: 3.303

8.  Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function.

Authors:  Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.

Authors:  Heidi Palosaari; Jean-Patrick Parisien; Jason J Rodriguez; Christina M Ulane; Curt M Horvath
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.

Authors:  Kaoru Takeuchi; Shin-ich Kadota; Makoto Takeda; Naoko Miyajima; Kyosuke Nagata
Journal:  FEBS Lett       Date:  2003-06-19       Impact factor: 4.124

View more
  24 in total

1.  Identification of RNA partners of viral proteins in infected cells.

Authors:  Anastassia V Komarova; Chantal Combredet; Odile Sismeiro; Marie-Agnès Dillies; Bernd Jagla; Raul Yusef Sanchez David; Nicolas Vabret; Jean-Yves Coppée; Pierre-Olivier Vidalain; Frédéric Tangy
Journal:  RNA Biol       Date:  2013-04-01       Impact factor: 4.652

2.  Upon Infection, Cellular WD Repeat-Containing Protein 5 (WDR5) Localizes to Cytoplasmic Inclusion Bodies and Enhances Measles Virus Replication.

Authors:  Dzwokai Ma; Cyril X George; Jason L Nomburg; Christian K Pfaller; Roberto Cattaneo; Charles E Samuel
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 3.  Proteomic approaches to the study of papillomavirus-host interactions.

Authors:  Elizabeth A White; Peter M Howley
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

4.  Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region.

Authors:  Ritsuko Koga; Yukihiko Sugita; Takeshi Noda; Yusuke Yanagi; Shinji Ohno
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

5.  Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.

Authors:  Marie-Anne Germain; Laurent Chatel-Chaix; Bridget Gagné; Éric Bonneil; Pierre Thibault; Fabrine Pradezynski; Benoît de Chassey; Laurène Meyniel-Schicklin; Vincent Lotteau; Martin Baril; Daniel Lamarre
Journal:  Mol Cell Proteomics       Date:  2013-10-29       Impact factor: 5.911

6.  High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses.

Authors:  Marianne Lucas-Hourani; Hélène Munier-Lehmann; Olivier Helynck; Anastassia Komarova; Philippe Desprès; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  J Vis Exp       Date:  2014-05-05       Impact factor: 1.355

7.  Expression and purification of recombinant Saccharomyces cerevisiae mitochondrial carrier protein YGR257Cp (Mtm1p).

Authors:  Mei M Whittaker; James W Whittaker
Journal:  Protein Expr Purif       Date:  2013-11-01       Impact factor: 1.650

Review 8.  Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics.

Authors:  Heng Zhu; Eric Cox; Jiang Qian
Journal:  Proteomics Clin Appl       Date:  2012-11-08       Impact factor: 3.494

9.  Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).

Authors:  Marianne Lucas-Hourani; Hélène Munier-Lehmann; Farah El Mazouni; Nicholas A Malmquist; Jane Harpon; Eloi P Coutant; Sandrine Guillou; Olivier Helynck; Anne Noel; Artur Scherf; Margaret A Phillips; Frédéric Tangy; Pierre-Olivier Vidalain; Yves L Janin
Journal:  J Med Chem       Date:  2015-06-30       Impact factor: 7.446

10.  Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity.

Authors:  Marianne Lucas-Hourani; Daniel Dauzonne; Pierre Jorda; Gaëlle Cousin; Alexandru Lupan; Olivier Helynck; Grégory Caignard; Geneviève Janvier; Gwénaëlle André-Leroux; Samira Khiar; Nicolas Escriou; Philippe Desprès; Yves Jacob; Hélène Munier-Lehmann; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.